SCHEMBL10656111

SCHEMBL10656111

Cc1nc2ccc(Cl)cc2c(-c2ccc(F)cc2)c1C/C=C/O

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.54
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
FABP3 P05413 3/20 0.46
FABP4 P15090 3/20 0.46
DHODH Q02127 2/20 0.43
PLA2G2A P14555 2/20 0.40
FABP5 Q01469 2/20 0.38
CASP3 P42574 1/20 0.38
HSP90AB1 P08238 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10656122 1.00 KDM4E (0.54) KDM4ELMNASMN1; SMN2FABP3FABP4
SCHEMBL10656158 0.84 KDM4E (0.59) KDM4ELMNASMN1; SMN2FABP3FABP4
SCHEMBL10656381 0.75 FABP3 (0.50) KDM4ELMNASMN1; SMN2FABP3FABP4
SCHEMBL3350429 0.75 KDM4E (0.70) KDM4ELMNASMN1; SMN2FABP3FABP4
SCHEMBL10659362 0.75 FABP4 (0.79) KDM4ELMNASMN1; SMN2FABP3FABP4
SCHEMBL10661744 0.72 FABP3 (0.47) KDM4ELMNASMN1; SMN2FABP3FABP4
SCHEMBL10658967 0.72 FABP3 (0.47) KDM4ELMNASMN1; SMN2FABP3FABP4
SCHEMBL3970472 0.72 RXFP1 (0.47) KDM4EDHODHCASP3
SCHEMBL3346066 0.71 KDM4E (0.71) KDM4ELMNASMN1; SMN2FABP3FABP4
SCHEMBL14390974 0.69 KDM4E (0.78) KDM4ELMNASMN1; SMN2FABP3FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4761419-A ANTILIPEMIC WARNER-LAMBERT COMPANY (US) 1988-08-02 US disclosed